Dr. David Diemert spoke with WTOP and Healio to discuss The NIH enrolling participants in a clinical trial to investigate the efficacy of fractional doses of monkeypox vaccine, and another trial evaluating the antiviral tecovirimat in adults and children with monkeypox.
David Diemert Discusses the MonkeyPox Clinical Trial at GW
Latest News
The ninth annual Art of Science competition highlights the beauty and elegance of ongoing research at GW SMHS.
Julie E. Bauman, MD, led a panel of leading cancer researchers who explored the future of cancer treatment as part of the GW Medicine Bicentennial Lecture Series. The hour-long lecture, titled “Harnessing the Immune System Against Cancer — From Shots to Stem Cells,” delved into innovative therapies…
The George Washington University School of Medicine and Health Sciences Department of Dermatology, in collaboration with the Pennsylvania Avenue Baptist Church and the National Psoriasis Foundation (NPF), announced a renewed funding commitment of $350,000 from Johnson & Johnson in support of…